Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Diseases × zimberelimab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 8 Stomach Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Lung Neoplasms 3 Carcinoma, Renal Cell 3 Recurrence 2 Pancreatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Kidney Neoplasms 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Solid Tumors 1 Solid Tumor 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Oligometastatic Prostate Cancer 1

Interventions

Carboplatin 9 Paclitaxel 5 pembrolizumab 4 Pemetrexed 4 Cisplatin 4 atezolizumab 3 zipalertinib 2 selpercatinib 2 pralsetinib 2 durvalumab 2 Nivolumab 2 Blood Specimen Collection 2 zimberelimab 1 taletrectinib 1 sotorasib 1 sitravatinib 1 sacituzumab govitecan 1 repotrectinib 1 ceralasertib 1 cemiplimab 1 alectinib 1 Vital Signs 1 Tomography, Emission-Computed, Single-Photon 1 Toll-Like Receptor 1 1 Telescopes 1 Radiosurgery 1 Omacor 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06431633 2025-04-10

ARIAN

Fundación GECP

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡